Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics

Psychedelics companies are all the rage right now. Compass Pathways is working with the magic mushroom compound psilocybin to treat depression. It’s has raised $290 million in total. Atai Life Sciences — backed by PayPal co-founder Peter Thiel — brought in $258 million from its IPO. In the tech space, this has not gone unnoticed and the same business models that have been used in other platforms for health and wellness startups are coming to psychedelics.

The latest is Journey Clinical, based out of NYC, which has raised a $3 million seed round led by San Francisco VC firm Fifty Years. Also participating were Neo Kuma Ventures, Palo Santo,

→ Continue reading at TechCrunch

More from author

Related posts

Advertisment

Latest posts

The Tantalizing Mystery of the Solar System’s Hidden Oceans

The original version of this story appeared in Quanta Magazine.For most of humankind’s existence, Earth was the only known ocean-draped world, seemingly unlike any...

The Role of Scholarships and Grants in Financing Education

Applying for scholarships and grants helps students pay for college. In some situations, these awards allow people to obtain a degree they wouldn't be...

EV, hybrid and gas-powered: Some interesting cars coming in 2024 | CNN Business

CNN  —  Next year will see the introduction of some new, genuinely affordable electric vehicles as well as...